CStone Pharmaceuticals Stock Deutsche Boerse AG
Stocks
PH4
KYG2588M1006
Pharmaceuticals
OTC Markets Traded|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.4804 EUR | -2.77% |
|
-0.81% | -15.72% |
| Market Cap | 6.37B 938M 824M 759M 710M 1.33B 88.48B 1.36B 9.1B 3.53B 43.61B 3.52B 3.44B 152B | P/E 2026 * |
-299x | P/E 2027 * | 5.95x |
|---|---|---|---|---|---|
| Enterprise Value | 5.84B 860M 755M 696M 651M 1.22B 81.14B 1.24B 8.35B 3.23B 40B 3.23B 3.16B 139B | EV / Sales 2026 * |
12.2x | EV / Sales 2027 * | 1.62x |
| Free-Float |
77.76% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: CStone Pharmaceuticals
| 1 day | -2.77% | ||
| 1 week | -0.81% | ||
| Current month | -43.13% | ||
| 1 month | -42.09% | ||
| 3 months | -36.37% | ||
| 6 months | -17.88% | ||
| Current year | -15.72% |
| 1 week | 0.48 |  | 0.54 |
| 1 month | 0.45 | | 0.86 |
| Current year | 0.45 | | 1.12 |
| 1 year | 0.44 | | 1.35 |
| 3 years | 0.09 | | 1.35 |
| 5 years | 0.09 | | 1.97 |
| 10 years | 0.09 | | 1.98 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jian Xin Yang
CEO | Chief Executive Officer | 62 | 25/08/2022 |
Wei Cong Ni
DFI | Director of Finance/CFO | - | 18/01/2023 |
Ying Hua Zhang
COO | Chief Operating Officer | 46 | 01/08/2016 |
| Director | Title | Age | Since |
|---|---|---|---|
Wei Li
CHM | Chairman | 55 | - |
Jian Xin Yang
BRD | Director/Board Member | 62 | 25/08/2022 |
Edward Hu
BRD | Director/Board Member | 63 | 09/07/2021 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.77% | -0.81% | - | - | 938M | |
| +2.97% | +3.49% | +21.66% | -19.19% | 63.09B | |
| +0.78% | +3.44% | +53.02% | +219.13% | 55.61B | |
| +0.07% | +38.60% | +38.60% | +38.60% | 41.64B | |
| -2.36% | -1.25% | -52.13% | -58.98% | 38.98B | |
| +6.50% | +4.38% | +64.24% | -25.97% | 29.82B | |
| +7.61% | +5.00% | +126.26% | -48.25% | 23.71B | |
| +4.96% | +11.18% | +62.76% | +83.11% | 21.48B | |
| -1.25% | -0.27% | -4.39% | +142.42% | 16.87B | |
| -1.19% | +3.73% | +65.97% | +121.83% | 16.74B | |
| Average | +1.42% | +2.98% | +41.78% | +50.30% | 34.22B | |
| Weighted average by Cap. | +1.75% | +2.91% | +36.30% | +47.39% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 479M 70.53M 61.95M 57.08M 53.37M 100M 6.66B 102M 685M 265M 3.28B 265M 259M 11.4B | 1.71B 252M 221M 204M 191M 358M 23.79B 364M 2.45B 948M 11.73B 947M 926M 40.75B |
| Net income | -243M -35.79M -31.43M -28.96M -27.08M -50.79M -3.38B -51.72M -347M -135M -1.66B -134M -131M -5.78B | 687M 101M 88.85M 81.86M 76.55M 144M 9.54B 146M 982M 380M 4.71B 380M 372M 16.35B |
| Net Debt | -528M -77.72M -68.27M -62.9M -58.81M -110M -7.33B -112M -755M -292M -3.62B -292M -285M -12.56B | -3.6B -530M -466M -429M -401M -752M -50.03B -766M -5.15B -1.99B -24.66B -1.99B -1.95B -85.7B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/06/26 | €0.4804 | -2.77% | 0 |
| 25/06/26 | €0.4941 | -5.31% | 0 |
| 24/06/26 | €0.5218 | -2.47% | 0 |
| 23/06/26 | €0.5350 | +5.94% | 6,004 |
| 22/06/26 | €0.5050 | +4.27% | 0 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 2616 Stock
- PH4 Stock
Select your edition
All financial news and data tailored to specific country editions
